Newly Diagnosed Multiple Myeloma
Showing 1 - 25 of >10,000
Guiding the Treatment in Older Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Frailty
- (no location specified)
Oct 30, 2023
Multiple Myeloma, Renal Failure Trial in Augusta (Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide,
Not yet recruiting
- Multiple Myeloma
- Renal Failure
- Daratumumab-hyaluronidase in Combination with Bortezomib, Cyclophosphamide, and Dexamethasone
-
Augusta, GeorgiaGeorgia Cancer Center-Augusta University
Nov 16, 2023
Stem Cells Mobilization, colLection and Engraftment in Newly
Recruiting
- Multiple Myeloma
- +3 more
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)
Recruiting
- Multiple Myeloma
- New Diagnosis Tumor
- BCMA CAR-T cells
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jan 31, 2023
Multiple Myeloma Trial in Cleveland (Palliative Care, FACT-MM questionnaire, HADS questionnaire)
Recruiting
- Multiple Myeloma
- Palliative Care
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023
MRD-tailored Therapy in Newly Diagnosed Multiple Myeloma With
Not yet recruiting
- Multiple Myeloma
- Minimal Residual Disease
- (no location specified)
Nov 1, 2023
Multiple Myeloma Prognostic Indices
Recruiting
- Multiple Myeloma
- Hematologic Diseases
- blood viscosity , albumin / fibrinogen ratio and red cell distribution
-
Assiut, EgyptAssiut University hospital
Oct 17, 2023
Daratumumab in Combination With Bortezomib, Thalidomide, and
Not yet recruiting
- Newly Diagnosed Multiple Myeloma
- Daratumumab in Combination with Bortezomib, Thalidomide, and Dexamethasone Regimens
- (no location specified)
Sep 27, 2022
Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)
Recruiting
- Newly Diagnosed Multiple Myeloma
- Daratumumab
- +4 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 29, 2022
Multiple Myeloma, Newly Diagnosed Multiple Myeloma (NDMM), Relapsed and/or Refractory Multiple Myeloma (RRMM) Trial run by the
Not yet recruiting
- Multiple Myeloma
- +2 more
- 18F-fluciclovine injection
- 18F-FDG PET/CT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 31, 2023
Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)
Active, not recruiting
- Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jan 10, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Multiple Myeloma, Tumors, Tumor, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Lenalidomide, Dexamethasone)
Not yet recruiting
- Multiple Myeloma
- +7 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Oct 11, 2022
Multiple Myeloma Trial in United States (daratumumab, carfilzomib, lenalidomide)
Active, not recruiting
- Multiple Myeloma
- daratumumab
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Dec 28, 2022
Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)
Recruiting
- Multiple Myeloma
- anti-BCMA CAR-T
- Selinexor-VRD
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital Chinese Acad
May 12, 2023
Multiple Myeloma Trial in Shanghai (GC012F injection)
Not yet recruiting
- Multiple Myeloma
- GC012F injection
-
Shanghai, Shanghai, ChinaShanghai Changzheng Hospital
May 1, 2023
Multiple Myeloma, Cancer Trial in Chapel Hill, Durham, Columbus (Isatuximab, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Cancer
- Isatuximab
- +2 more
-
Chapel Hill, North Carolina
- +2 more
Jun 30, 2022
Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +2 more
-
Torino, ItalyFondazione EMN Italy Onlus
Mar 24, 2022
Multiple Myeloma Trial in Torino (Carfilzomib, Cyclophosphamide, Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib
- +2 more
-
Torino, ItalyFondazione EMN Italy Onlus
Mar 24, 2022
Multiple Myeloma Trial in Worldwide (Elranatamab, Daratumumab, Lenalidomide)
Recruiting
- Multiple Myeloma
- Elranatamab
- +3 more
-
Nagaizumi-cho,Sunto-gun, Shizuoka, Japan
- +7 more
Jan 9, 2023